2021
DOI: 10.1016/j.abd.2021.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Kaposi’s sarcoma: a single-center experience on 38 patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 7 publications
0
2
0
1
Order By: Relevance
“…A escolha do tratamento deve ser, portanto, individualizada levando em consideração a gravidade do caso, extensão e localização das lesões e comprometimento do sistema imunológico, de tal modo que os objetivos terapêuticos para cada paciente também possam ser individuais, embora tenham apresentações semelhantes da doença (CALVÃO, CARDOSO, VIEIRA, 2021).…”
Section: Metodologiaunclassified
“…A escolha do tratamento deve ser, portanto, individualizada levando em consideração a gravidade do caso, extensão e localização das lesões e comprometimento do sistema imunológico, de tal modo que os objetivos terapêuticos para cada paciente também possam ser individuais, embora tenham apresentações semelhantes da doença (CALVÃO, CARDOSO, VIEIRA, 2021).…”
Section: Metodologiaunclassified
“…Kaposi sarcoma (KS) is the most common neoplasm of patients with human immunodeficiency virus (HIV) infection [ 1 ]. In the antiretrovirals era, the incidence of KS decreased from 15.2/1000 patient-year to 4.9/1000 patient-year and so; nowadays, KS is an unusual presentation of HIV [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…In the antiretrovirals era, the incidence of KS decreased from 15.2/1000 patient-year to 4.9/1000 patient-year and so; nowadays, KS is an unusual presentation of HIV [ 2 ]. KS is a multifocal angioproliferative neoplasm associated with the infection by human herpes virus type 8 (KSHV) [ 1 ]. KSHV has been shown to be the etiologic agent for several other tumors and diseases, including primary effusion lymphoma (PEL), an extracavitary variant of PEL, KS-associated diffuse large B-cell lymphoma, a form of multicentric Castleman disease (MCD), and KS inflammatory cytokine syndrome (KICS).…”
Section: Introductionmentioning
confidence: 99%